Literature DB >> 34359593

Is There One Key Step in the Metastatic Cascade?

Antoine M Dujon1,2, Jean-Pascal Capp3, Joel S Brown4, Pascal Pujol1,5, Robert A Gatenby4, Beata Ujvari2,6, Catherine Alix-Panabières1,7, Frédéric Thomas1.   

Abstract

The majority of cancer-related deaths are the result of metastases (i.e., dissemination and establishment of tumor cells at distant sites from the origin), which develop through a multi-step process classically termed the metastatic cascade. The respective contributions of each step to the metastatic process are well described but are also currently not completely understood. Is there, for example, a critical phase that disproportionately affects the probability of the development of metastases in individual patients? Here, we address this question using a modified Drake equation, initially formulated by the astrophysicist Frank Drake to estimate the probability of the emergence of intelligent civilizations in the Milky Way. Using simulations based on realistic parameter values obtained from the literature for breast cancer, we examine, under the linear progression hypothesis, the contribution of each component of the metastatic cascade. Simulations demonstrate that the most critical parameter governing the formation of clinical metastases is the survival duration of circulating tumor cells (CTCs).

Entities:  

Keywords:  Drake equation; circulating tumor cells; metastasis; metastatic process

Year:  2021        PMID: 34359593     DOI: 10.3390/cancers13153693

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  4 in total

Review 1.  Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence.

Authors:  Nahlah Makki Almansour
Journal:  Front Mol Biosci       Date:  2022-01-25

2.  Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients.

Authors:  Elena Muraro; Fabio Del Ben; Matteo Turetta; Daniela Cesselli; Michela Bulfoni; Rita Zamarchi; Elisabetta Rossi; Simon Spazzapan; Riccardo Dolcetti; Agostino Steffan; Giulia Brisotto
Journal:  Front Oncol       Date:  2022-08-23       Impact factor: 5.738

3.  Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial.

Authors:  Elisabeth K Trapp; Peter A Fasching; Tanja Fehm; Andreas Schneeweiss; Volkmar Mueller; Nadia Harbeck; Ralf Lorenz; Claudia Schumacher; Georg Heinrich; Fabienne Schochter; Amelie de Gregorio; Marie Tzschaschel; Brigitte Rack; Wolfgang Janni; Thomas W P Friedl
Journal:  Cancers (Basel)       Date:  2022-08-16       Impact factor: 6.575

4.  Dissemination of circulating tumor cells at night: role of sleep or circadian rhythm?

Authors:  Yves Dauvilliers; Frédéric Thomas; Catherine Alix-Panabières
Journal:  Genome Biol       Date:  2022-10-14       Impact factor: 17.906

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.